Akesis’ Stereotactic Radiosurgery System Nabs FDA Clearance

Akesis received 510(k) clearance for its Galaxy RTx product, an advanced gamma stereotactic radiosurgery system for use in intracranial radiosurgeries.

The system features 360-degree rotational delivery to give more flexibility in dose distribution compared to traditional radiosurgery devices. It also provides real-time, in-line imaging.

“With a radiologic accuracy of <0.5mm, the Akesis Galaxy…provides sharp dose fall-off and potentially better sparing of organs at risk,” the company said.